Orthofix Medical Inc. (OFIX) Stock

Orthofix Medical Inc. is a prominent player in the medical device and biologics industry, operating across the United States, Italy, Germany, France, the United Kingdom, Brazil, and globally. The company is structured into two main segments: Global Spine and Global Orthopedics.

Within the Global Spine segment, Orthofix manufactures and distributes bone growth stimulator devices, which promote bone fusion and serve as therapeutic treatments for non-spinal and appendicular fractures. This segment also develops a comprehensive portfolio of motion preservation and fixation implant products for spine surgeries, along with a range of products and tissue forms that enable physicians to address various spinal and orthopedic conditions. Additionally, Orthofix markets regenerative non-tissue biologic solutions derived from synthetic materials.

The Global Orthopedics segment focuses on designing, developing, and marketing orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. These products are essential tools in enhancing patient outcomes across orthopedic surgical interventions.

Orthofix Medical Inc. distributes its innovative product portfolio through a diversified sales network that includes direct sales representatives, independent distributors, and employed and independent sales representatives. Its custtomer base spans physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other healthcare purchasing organizations, ensuring broad accessibility to its advanced medical solutions.

Founded in 1980 and headquartered in Lewisville, Texas, Orthofix Medical Inc. has evolved significantly since its inception. Formerly known as Orthofix International N.V., the company rebranded to Orthofix Medical Inc. in July 2018, marking a strategic shift in its focus on advancing medical technologies and biologics to improve patient care worldwide.